Business
US approves at-home COVID test from Brisbane company Ellume Health – NEWS.com.au
US awards $304 million contract to Brisbane-based Ellume for at-home COVID test
The US government is awarding nearly $304 million to a Brisbane-based biotech firm to scale up production of its rapid at-home COVID-19 diagnostic test, officials said Monday.Ellume’s coronavirus home test kit received an emergency use authorisation from the US Food and Drug Administration (FDA) in December.
The test, which uses a nasal swab and can be purchased without a prescription, can be performed at home with results reported via smartphone app within 15 minutes.
It detects COVID-19 with 95…
-
Business24 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News24 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage
-
Business21 hours agoDoes Macquarie rate Rio Tinto shares a buy, hold or sell after its big news?
-
General24 hours agoBusiness boost as more nuisance tariffs get the chop